Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, Big_Money_Upward
Search This Board:
Last Post: 8/22/2014 3:42:33 PM - Followers: 271 - Board type: Free - Posts Today: 0
NYSE now, upgraded from OTC!                                 

 As of Thu, Jul 11, 2013, ONVO trades on NYSE Amex. 

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

   Organovo Support Chart

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 08/21/2014 04:33:19 PM
ONVO News: Current Report Filing (8-k) 08/12/2014 04:07:43 PM
ONVO News: Quarterly Report (10-q) 08/08/2014 05:16:42 PM
ONVO News: Organovo Announces Appointment of Gregory T. Lucier as Corporate Advisor 08/06/2014 08:05:00 AM
ONVO News: Current Report Filing (8-k) 07/24/2014 08:06:35 AM
#6303  Sticky Note 3D BioPrinter ==='s Print a kidney! Big_Money_Upward 06/27/14 12:54:46 PM
#6278  Sticky Note ONVO news: "Organovo Reports Positive Results from a rayank 06/26/14 10:25:47 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#6648   add when you can dshade 08/22/14 03:42:33 PM
#6647   entire 3d printer sector moving Big_Money_Upward 08/22/14 10:17:59 AM
#6646   joy. Yellen speaks again. lol dshade 08/22/14 09:37:20 AM
#6645   Thanks Operator... grantg2 08/22/14 09:21:21 AM
#6644   no registration required ... took like 2 mins... Hello Operator 08/22/14 08:59:14 AM
#6643   Perhaps someone will do us a favor by grantg2 08/21/14 10:47:28 PM
#6642   If you go on the Yahoo message board,, bigideaportugal 08/21/14 07:35:57 PM
#6641   8-K filed after hours.... grantg2 08/21/14 05:52:27 PM
#6640   I actually see $7.00 as support on all rayank 08/21/14 04:45:24 PM
#6639   More than 114,300 people are waiting for an dshade 08/21/14 04:24:19 PM
#6638   I use Ichiban and it says we break dshade 08/21/14 03:41:28 PM
#6637   UNFORTUNATELY NO... the ichimoku cloud chart for ONVO grantg2 08/21/14 03:06:16 PM
#6636   ONVO Chart, do you see what i see: [IMG][/I Big_Money_Upward 08/21/14 01:57:50 PM
#6635   they usually release a summary of meeting a dshade 08/21/14 12:24:57 PM
#6634   added dshade 08/21/14 11:06:16 AM
#6633   was the shareholder's meeting today? stocker83 08/20/14 09:58:46 AM
#6632   7.77 again dshade 08/19/14 04:35:26 PM
#6631   nice. enjoy. dig deep. lol dshade 08/19/14 11:41:41 AM
#6630   Keith Murphy a Featured Speaker in October 3DPrintInvestor 08/19/14 10:40:34 AM
#6629   Read this on their fb page. Good news stuinvest 08/18/14 04:06:09 PM
#6628   Makerbot founder Bre Pettis says 3D printed organs RallyTheMarket 08/18/14 11:12:40 AM
#6627   good post on the yahoo ONVO message board 2014trader 08/16/14 03:57:19 PM
#6626   so keep adding as ONVO keeps adding potent dshade 08/16/14 03:28:34 PM
#6625   Remember, Mr. Lucier was formerly Chairman and CEO dshade 08/16/14 03:21:02 PM
#6624   this year’s annual meeting of stockholders of Organovo Big_Money_Upward 08/15/14 01:26:31 PM
#6623   Keith Murphy, chairman and chief executive officer of RandolRocketman 08/15/14 01:26:16 PM
#6622   buy US Biotech like this dshade 08/15/14 01:11:17 PM
#6621   ZZZ VOLUME. Shorts using Russia now. lol dshade 08/15/14 01:10:43 PM
#6620   Same. Sold @ 8.12 and reloaded today. We jjh573 08/15/14 01:00:41 PM
#6619   bought more today Big_Money_Upward 08/15/14 11:03:09 AM
#6618   Organovo moves towards launch of a major new Big_Money_Upward 08/14/14 05:52:08 PM
#6617   nice block. shareholder meeting upcoming Wednesday. Big_Money_Upward 08/14/14 05:48:36 PM
#6616   noticed that too... can't find any news... anyone? kamwjm 08/14/14 05:06:09 PM
#6615   after hours. t-trade for 250,000 shares at $7.95 2014trader 08/14/14 04:55:57 PM
#6614   longs can kick shorts all over as biotech dshade 08/14/14 04:19:28 PM
#6613   Just my opinion, but I think the shorts Alvie 08/14/14 03:59:40 PM
#6612   Thank you. I hope you are right. rumper 08/14/14 03:09:05 PM
#6611   LOW vol game. almost to the add point dshade 08/14/14 03:07:52 PM
#6610   when the depth of Roche deal gets deeper, squeeze dshade 08/14/14 01:57:37 PM
#6609   over 25% of the float short is great Mister Dude 08/14/14 12:49:33 PM
#6608   Oh don't worry. This is around the level RandolRocketman 08/14/14 11:47:29 AM
#6607   Institutions owning LONG increased too dshade 08/14/14 10:45:25 AM
#6606   they will fail as usual here dshade 08/14/14 10:39:25 AM
#6604   Short interest, all time high rumper 08/14/14 10:25:39 AM
#6603   lately they try short in morn to prevent dshade 08/14/14 10:15:33 AM
#6602   i like when it creeps up slowly, rather Big_Money_Upward 08/13/14 06:22:43 PM
#6600   low vol shake dshade 08/13/14 12:34:46 PM
#6599   smart move dshade 08/13/14 11:23:33 AM
#6598   having some trouble placing an order. [IMG][/IMG] Big_Money_Upward 08/13/14 11:22:41 AM
#6597 rayank 08/13/14 08:14:28 AM